Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000893838-07-000189
Filing Date
2007-06-13
Accepted
2007-06-13 16:14:01
Documents
1
Period of Report
2007-06-11

Document Format Files

Seq Description Document Type Size
1 frm4kang061207_ex.html 4  
1 frm4kang061207_ex.xml 4 4992
  Complete submission text file 0000893838-07-000189.txt   6912
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address REXAHN PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 240-268-5300
Kang Y Michele (Reporting) CIK: 0001361685 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50590 | Film No.: 07917644